Naoya Sato

Chief Administrative Officer at ANGES, INC.

66 year

Health Technology

Consumer Services

Finance

Profile

Naoya Sato is currently Director & Administration Manager at AnGes, Inc. since 2025.
Formerly, Dr. Sato was Director-Business Development at Tanabe Pharma Corp.
from 2019 to 2025 and Director at MP Healthcare Venture Management, Inc. from 2015 to 2019.
Education includes undergraduate, graduate, and doctorate degrees from Osaka University, all conferred in 1993.

Naoya Sato active positions

Companies	Position	Start
ANGES, INC.	Chief Administrative Officer	31/07/2024

All active positions of Naoya Sato

Former positions of Naoya Sato

Companies	Position	End
MITSUBISHI TANABE PHARMA CORPORATION	Director/Board Member	22/06/2025
MP Healthcare Venture Management, Inc. MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture invests in companies located in the North America and Europe. The firm focuses on sectors such as biotechnology, biopharmaceuticals, therapeutics and diagnostics. It participates in seed and early stage capital transactions.	Director/Board Member	-

See the detail of Naoya Sato's experience

Training of Naoya Sato

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Naoya Sato's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Mitsubishi Tanabe Pharma Corp. Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products	Health Technology
AnGes, Inc. AnGes, Inc. Pharmaceuticals: GenericHealth Technology Manufactures gene pharmaceutical medicines	Health Technology
Osaka University Osaka University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
MP Healthcare Venture Management, Inc. MP Healthcare Venture Management, Inc. Investment ManagersFinance MP Healthcare Venture invests in companies located in the North America and Europe. The firm focuses on sectors such as biotechnology, biopharmaceuticals, therapeutics and diagnostics. It participates in seed and early stage capital transactions.	Finance

See company connections